Secondary VTE prevention study: time to first recurrence of VTE, major or minor bleeding events, and PTS, on-treatment, by thrombophilia status
| . | Thrombophilia . | Thrombophilia negative/unknown . | ||
|---|---|---|---|---|
| Overall (N = 106) . | Major (N = 73) . | Minor (N = 33) . | (N = 107) . | |
| Recurrence of VTE, n (%) | ||||
| At 3 mo | 2 (1.9) | 1 (1.4) | 1 (3.0) | 0 |
| At 6 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| At 12 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| Any bleeding event, n (%) | ||||
| At 3 mo | 20 (18.9) | 13 (17.8) | 7 (21.2) | 11 (10.3) |
| At 6 mo | 25 (23.6) | 16 (21.9) | 9 (27.3) | 16 (15.0) |
| At 12 mo | 29 (27.4) | 19 (26.0) | 10 (30.3) | 19 (17.8) |
| MBE, n (%) | ||||
| At 3 mo | 0 | 0 | 0 | 1 (0.9) |
| At 6 mo | 0 | 0 | 0 | 2 (1.9) |
| At 12 mo | 1 (0.9) | 1 (1.4) | 0 | 2 (1.9) |
| CRNM, n (%) | ||||
| At 3 mo | 0 | 0 | 0 | 0 |
| At 6 mo | 1 (0.9) | 1 (1.4) | 0 | 1 (0.9) |
| At 12 mo | 2 (1.9) | 2 (2.7) | 0 | 1 (0.9) |
| PTS, n (%) | ||||
| At 3 mo | 2 (1.9) | 1 (1.4) | 1 (3.0) | 0 |
| At 6 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| At 12 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| . | Thrombophilia . | Thrombophilia negative/unknown . | ||
|---|---|---|---|---|
| Overall (N = 106) . | Major (N = 73) . | Minor (N = 33) . | (N = 107) . | |
| Recurrence of VTE, n (%) | ||||
| At 3 mo | 2 (1.9) | 1 (1.4) | 1 (3.0) | 0 |
| At 6 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| At 12 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| Any bleeding event, n (%) | ||||
| At 3 mo | 20 (18.9) | 13 (17.8) | 7 (21.2) | 11 (10.3) |
| At 6 mo | 25 (23.6) | 16 (21.9) | 9 (27.3) | 16 (15.0) |
| At 12 mo | 29 (27.4) | 19 (26.0) | 10 (30.3) | 19 (17.8) |
| MBE, n (%) | ||||
| At 3 mo | 0 | 0 | 0 | 1 (0.9) |
| At 6 mo | 0 | 0 | 0 | 2 (1.9) |
| At 12 mo | 1 (0.9) | 1 (1.4) | 0 | 2 (1.9) |
| CRNM, n (%) | ||||
| At 3 mo | 0 | 0 | 0 | 0 |
| At 6 mo | 1 (0.9) | 1 (1.4) | 0 | 1 (0.9) |
| At 12 mo | 2 (1.9) | 2 (2.7) | 0 | 1 (0.9) |
| PTS, n (%) | ||||
| At 3 mo | 2 (1.9) | 1 (1.4) | 1 (3.0) | 0 |
| At 6 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |
| At 12 mo | 3 (2.8) | 2 (2.7) | 1 (3.0) | 0 |